The Cro Market Outlook: Emerging Markets, Leading Players And Future Trends : Market Research Report

The Cro Market Outlook: Emerging Markets, Leading Players And Future Trends

Published: May. 1, 2007 - 172 Pages

The CRO Market Outlook: Executive Summary; The global contract research organization market; CRO market analysis; Regional analysis of the CRO market; Leading players in the global CRO market; The future of contract research
Chapter 1 The global contract research: organization market; Summary; Introduction; The CRO contribution to drug development; Market overview; Key market drivers; Key market restraints; Conclusions and key findings; Overview of the global CRO market; Total revenue forecasts; Global R&D expenditure and CRO market size; Global clinical development outsourcing; The contribution of CRO to drug development; Current market drivers; Growth of R&D expenditure from biotech and pharma; Cost pressures encourage R&D outsourcing; Strong growth and R&D expenditure of biotechnology companies; Growing regulatory burden and safety concerns; US; EU; Patient recruitment; Strong demand for early development services; The development of biomarkers; Current market restraints; Growing competition and customer consolidation; New financial realities alter biopharmaceutical outsourcing landscape; Shortage of clinical research personnel; Electronic data capture: a threat to CRO revenue; Key market trends; Globalization; EDC evolution; Strategic partnerships
Chapter 2 CRO market analysis: Summary; Introduction; Competitive analysis; Market share analysis; Competitive dynamics; Academic Medical Centers; Site management organizations; Laboratory analytical services; Non-CRO niche service providers; Conclusions; CRO service models; Introduction; The full service model; SWOT analysis; The niche model; SWOT analysis; Industry strategies; Consolidation: Mergers & acquisitions in the CRO industry; Expanding the continuum of services: vertical integration; Forward integration; Backward integration; Industry challenges; Consolidation within the CRO industry: a threat to close customer; relationships; Strategic outsourcing: demonstrating clear value to clients; Co-Development: sharing the risk
Chapter 3 Regional analysis of the CRO: market; Summary; Introduction; The US CRO Market; Overview; Drivers of the US CRO Market; Strong R&D development; Robust biotech funding; Increasing cost pressure; Aging population; Increased regulatory environment; Challenges of the US CRO Market; Patient recruitment; Local clinical trial costs; Competitive dynamics; The CRO Market in Western Europe; Overview; Infrastructure and local regulations; Drivers of the CRO market in Western Europe; Challenges of the CRO Market in Western Europe; Competitive dynamics; The Central and Eastern European CRO market; Overview; Infrastructure and local regulations; The benefits of the CEE CRO market; Challenges of the CEE CRO market; Competitive dynamics; The CRO market in China; Overview; Infrastructure and local regulations; The benefits of outsourcing to China; The challenges of outsourcing to China; Competitive dynamics; The CRO market in India; Overview; Infrastructure and local regulations; Intellectual property; Legislative reforms; The benefits of outsourcing to India; The challenges of outsourcing to India; Competitive dynamics; The CRO market in Latin America; Overview; Infrastructure and local regulations; Argentina; Brazil; Mexico; The benefits of outsourcing to Latin America; The challenges of outsourcing to Latin America; Competitive dynamics
Chapter 4 Leading players in the global: CRO market; Summary; Introduction; The client perspective; Capabilities of leading CROs; Quintiles Transnational Corp; Company profile; Business description; Global operations and recent deals; Covance; Company profile; Business description; Partnering collaborations and recent deals; PPD Inc.; Company profile; Business description; Partnering collaborations and recent deals; Charles River Laboratories; Company Profile; Business description; Partnering collaborations and recent deals; PAREXEL International; Company profile; Business description; Partnering collaborations and recent deals; MDS Inc; Company profile; Business description; Partnering collaborations and recent deals; ICON plc.; Company profile; Business description; Partnering collaborations and recent deals; PharmaNet Development Group; Company profile; Business description; Partnering collaborations and recent deals; Kendle International; Company profile; Business description; Partnering collaborations and recent deals; Omnicare Clinical Research; Company profile; Business description; Partnering collaborations and recent deals
Chapter 5 The future of contract research: Summary; Introduction; The shift towards a strategic model; Emerging markets and the future of CROs; Emerging markets; India; China; Central and Eastern Europe; Latin America; Africa; Conclusions; Electronic Data Capture and the future eCRO; Biomarkers; Conclusion; Key findings and conclusions
Chapter 6 Appendix: Bibliography; Index
List of Figures: Figure 1.1: Estimated CRO total market revenues, 2000-2010e; Figure 1.2: Global development expenditure and CRO market forecast, 2004-2010e; Figure 1.3: Global expenditure on clinical development and CRO market forecast 2004-2010e; Figure 1.4: Days actual submission exceeded projected submission date; Figure 1.5: Clinical research personnel, ACRO Members, 2002-2008e; Figure 1.6: Global pharmaceutical R&D expenditure, 2000-2008e; Figure 1.7: Comparison of drug development cost estimates; Figure 1.8: Global biotech R&D expenditure, 2004-2010e; Figure 1.9: Total EDC Provider Revenue and Revenue Loss by CROs; Figure 2.10: Market share of major players, 2006; Figure 2.11: Top five CROs market share trends, 2001-2007e; Figure 2.12: Typical full service CRO model; Figure 3.13: Geographic distribution of clinical trials, 1998 and 2008; Figure 3.14: R&D expenditures of PhRMA members and non-member companies, 1980-2006; Figure 3.15: US Clinical trials by therapeutic category, 2005; Figure 3.16: Overall indexed clinical trial costs, 2006; Figure 3.17: US CROs market share, 2005; Figure 3.18: The European CRO market - revenue forecast 2004-2010e; Figure 3.19: Pharmaceutical R&D expenditure in Europe, 1990-2005; Figure 3.20: Percentage of outsourced R&D work by type of organization, 2005; Figure 3.21: European CRO market - market share by company, 2005; Figure 3.22: Clinical trial costs of European countries compared to UK; Figure 3.23: Comparison of registration periods in CEE countries; Figure 3.24: Revenue forecasts, China 2006-2011e; Figure 3.25: China’s capabilities across the value chain; Figure 3.26: Revenue forecasts, India 2006-2011; Figure 3.27: Clinical trials by Latin American country, 2006; Figure 3.28: Distribution of the Latin American pharmaceutical market, 2005; Figure 4.29: Revenue growth of top CROs in 2006; Figure 4.30: Capabilities of leading CROs, 2007; Figure 4.31: MDS business units 2005 vs. 2008; Figure 4.32: Comparison of ICON sales growth vs. main competitors; Figure 5.33: Attractiveness of geographic regions for patient recruitment; Figure 5.34: Electronic data capture market size, 2001-2007
List of Tables: Table 1.1: Types of relationships between CROs and pharma companies; Table 2.2: The global R&D outsourcing market: five major segments; Table 2.3: SWOT analysis: the full service model; Table 2.4: SWOT analysis: the niche model; Table 3.5: Domestic CROs; Table 3.6: Major multinational CROs in China; Table 3.7: India’s capabilities across the value chain; Table 3.8: Major CROs (global & domestic) operating in Latin America, 2006; Table 4.9: Revenues ($m) and growth of major CROs, 2005-6; Table 5.10: EDC Promoters

Abstract

The CRO Market Outlook

Over the last decade rising pressure to reduce costs and time-to-market has lead to a rapid expansion of the global Contract Research Organization (CRO) market. Pharmaceutical and biotechnology company spend on CRO services has shown double digit growth in the past years highlighting the importance of this fast growing market.

The CRO Market Outlook assesses the drivers and restraints of the global CRO market, highlighting key trends and identifying offshore outsourcing opportunities in fast-growing emerging markets such as China, India and Latin America. This report also profiles the major international CRO players providing market share data and detailed analysis on current and future R&D spend.

Use this report to improve your understanding of the evolving CRO business models and ensure that you are able to implement the optimal outsourcing strategy for your company’s needs.

Key findings of the report...

The total CRO market size is estimated at $14bn in 2006 and expected to grow at an annual rate of 14-16% to reach $24bn through 2010. The market is highly fragmented and the number of CROs worldwide has reached over 1,100 despite continued consolidation.
CROs provide substantial global capacity to drug developers and have become critical contributors to clinical trial activity. Clinical trials conducted by CROs are completed up to 30% more quickly than those conducted in-house by pharma companies.
Of the large, global contract research providers, Quintiles is market leader, with 14% of the global market share, followed by Covance and PPD, holding 10% each. The five largest CROs have increased their market share and now hold 45% of the total market.
The leading CROs are commodity full service providers operating on a global scale. They act as one-stop shops for all services, from preclinical through marketing.
CROs and pharmaceutical companies are turning to strategic partnerships to gain a competitive edge in the global business environment.

Key questions answered in this report

What will the size and growth of the global CRO market be through 2010?
Which companies are current and future key players in the CRO market?
What kind of business relationships will pharma companies and CRO establish in the future?
Which business model approach will CROs adopt?
Where will future CROs be based?
What is limiting contract research in traditional markets?
What impact will Electronic Data Capture have on the clinical trials industry?
How will biomarkers influence the R&D work of CROs?

Top five reasons to order your copy today

Examine key trends which are currently affecting the market such as globalization, consolidation, Electronic Data Capture, strategic partnerships with clients and the future use of biomarkers in clinical research.
Analyze of the most important challenges affecting the clinical research industry such as growing competition, the shortage of clinical research personnel and patient recruitment.
Gain access to company analysis and market share for each of the major international players, including Quintiles, Covance, PPD, Charles River Laboratories and PAREXEL.
Evaluate outsourcing trends including new technologies, novel contract alliances within the industry and emerging CRO markets.
Understand the evolving CRO business models and ensure that you are able to implement the optimal outsourcing strategy for your company’s needs.

Get Full Details About This Report >>

US: 800.298.5699

Int'l: +1.240.747.3093

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 160,000 market research reports, company profiles and country profiles from over 600 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.

The Cro Market Outlook: Emerging Markets, Leading Players And Future Trends

Table of Contents

Abstract